Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser plus injection may improve scar healing

NCT ID NCT07472192

Symptom relief Sponsor: Misr University for Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding PDRN injections to standard CO2 laser therapy helps facial scars heal better and look less noticeable. It includes 36 adults with recent scars from cuts or surgery. The goal is to see if the combination is safer and more effective than laser alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Polydeoxyribonucleotide (PDRN) injections
What this could lead to
If it works, this could offer a more effective way to reduce facial scars and speed up healing after injury or surgery.
What could go wrong
This is a small, early-phase trial with only 36 people. The added benefit of PDRN may be minimal, and there is a risk of allergic reaction to PDRN.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age Limitations: Participants must be between 18 and 50 years of age. * Recently cut wounds or surgical scars from about (1-6 months). * Consent to Participate: Willingness to provide informed consent and engage in all aspects of the study. Exclusion Criteria: * Pregnancy or breastfeeding at the time of study. * Known allergy to PDRN. * Medication use that could affect wound healing or inflammation, such as: * Isotretinoin. * Anticancer drugs. * High-dose corticosteroids. * Anticoagulants. * Uncontrolled medical diseases (e.g., unstable diabetes, cardiac conditions).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial scarring are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial scarring

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Misr University for Science and Technology

    RECRUITING

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.